Non-proprietary names from 'fennel' to 'fluocortolone' - Electronic medicinal guide TALKDRUGS

X.J00-J06.J04   Acute laryngitis and tracheitis

X.J10-J18.J15   Bacterial pneumonia, not elsewhere classified

X.J20-J22.J20   Acute bronchitis

XVIII.R10-R19.R10.4   Other and unspecified abdominal pain

XVIII.R10-R19.R14   Meteorism and related conditions

X.J00-J06.J04   Acute laryngitis and tracheitis

X.J10-J18.J15   Bacterial pneumonia, not elsewhere classified

X.J20-J22.J20   Acute bronchitis

X.J30-J39.J37   Chronic laryngitis and laryngotracheitis

X.J40-J47.J42   Chronic bronchitis, unspecified

X.J40-J47.J45   Asthma

VII.H30-H36.H34   Vascular occlusion of the retina

VII.H55-H59.H57.8   Other unspecified diseases of the eye and adnexa

IX.I20-I25.I21   Acute myocardial infarction

IX.I26-I28.I26   Pulmonary embolism

IX.I60-I69.I63   Cerebral infarction

IX.I70-I79.I74   Embolism and thrombosis of the arteries

IX.I80-I89.I80   Phlebitis and thrombophlebitis

IX.I80-I89.I82   Embolism and thrombosis of other veins

IX.I26-I28.I26.9   Pulmonary embolism without mention of an acute pulmonary heart

IX.I60-I69.I66.9   Occlusion and stenosis of the cerebral artery, unspecified

III.D70-D77.D70   Agranulocytosis

III.D70-D77.D71   Functional disorders of polymorphonuclear neutrophils

III.D70-D77.D72   Other disorders of white blood cells

XIX.T66-T78.T78.8   Other adverse reactions, not elsewhere classified

IX.I10-I15.I15   Secondary Hypertension

IX.I10-I15.I10   Essential [primary] hypertension

XIV.N40-N51.N40   Hyperplasia of the prostate

XVIII.R30-R39.R39.1   Other difficulties associated with urination

VI.G35-G37.G35   Multiple sclerosis

IV.E70-E90.E78.2   Mixed hyperlipidemia

IX.I20-I25.I25.1   Atherosclerotic Heart Disease

V.F30-F39.F31   Bipolar affective disorder

V.F30-F39.F32   Depressive episode

V.F30-F39.F33   Recurrent depressive disorder

V.F40-F48.F41.2   Mixed anxiety and depressive disorder

V.F40-F48.F42   Obsessive-compulsive disorder

II.C81-C96.C82.9   Follicular non-Hodgkin's lymphoma, unspecified

II.C81-C96.C83   Diffuse non-Hodgkin's lymphoma

II.C81-C96.C85   Other and unspecified types of non-Hodgkin's lymphoma

II.C81-C96.C91.1   Chronic lymphocytic leukemia

II.C69-C72.C71   Malignant neoplasm of brain

II.C76-C80.C76   Malignant neoplasm of other and inaccurately marked localizations

V.F40-F48.F48.9   Neurotic disorder, unspecified

VI.G20-G26.G20   Parkinson's disease

VI.G20-G26.G21   Secondary Parkinsonism

VI.G40-G47.G40   Epilepsy

VI.G90-G99.G96.9   Disorder of central nervous system, unspecified

IX.I20-I25.I25   Chronic ischemic heart disease

IX.I30-I52.I50.1   Left ventricular failure

IX.I60-I69.I67.9   Cerebrovascular disease, unspecified

XIX.S00-S09.S06   Intracranial injury

IV.E20-E35.E25   Adrenogenital disorders

IV.E20-E35.E27.1   Primary insufficiency of the adrenal cortex

IV.E20-E35.E27.4   Other and unspecified adrenocortical insufficiency

IV.E70-E90.E86   Reduction of the volume of the liquid

IX.I95-I99.I95   Hypotension

IX.I95-I99.I95.9   Hypotension, unspecified

VII.H10-H13.H10.1   Acute atopic conjunctivitis

VII.H15-H22.H16   Keratite

XIX.S00-S09.S05   Injury of the eye and orbit

I.B20-B24.B20.5   The disease caused by HIV, with manifestations of other mycoses

I.B20-B24.B20.4   The disease caused by HIV, with manifestations of candidiasis

I.B35-B49.B35.4   Mycosis of the trunk

I.B35-B49.B35.3   Mycosis of the feet

I.B35-B49.B35.2   Mycosis brushes

I.B35-B49.B35.1   Mycosis of nails

I.B35-B49.B35.0   Mycosis of the beard and head

I.B35-B49.B35.6   Epidermophytosis inguinal

I.B35-B49.B36.0   Multicolored lichen

I.B35-B49.B37.0   Candidiasis stomatitis

I.B35-B49.B37.7   Candida septicemia

I.B35-B49.B37.6   Candidiasis endocarditis (I39.8 *)

I.B35-B49.B37.4   Candidiasis of other urogenital localizations

I.B35-B49.B37.3   Candidiasis of the vulva and vagina (N77.1 *)

I.B35-B49.B37.2   Candidiasis of skin and nails

I.B35-B49.B37.1   Pulmonary Candidiasis

I.B35-B49.B37.8   Candidiasis of other localizations

I.B35-B49.B38   Coccidioidomycosis

I.B35-B49.B39   Histoplasmosis

I.B35-B49.B41   Paracoccidioidomycosis

I.B35-B49.B42   Sporotrichosis

I.B35-B49.B45   Cryptococcosis

I.B35-B49.B45.2   Cutaneous Cryptococcosis

I.B35-B49.B45.1   Cerebral Cryptococcosis

I.B35-B49.B45.0   Pulmonary cryptococcosis

XIV.N40-N51.N51.2 *   Balanitis in diseases classified elsewhere

XX.Y85-Y89.Y88.0   Consequences of adverse effects of medicinal products, medicines and biological substances used for therapeutic purposes

XXI.Z40-Z54.Z51.1   Chemotherapy for neoplasm

XXI.Z40-Z54.Z51.0   Radiotherapy course (supportive)

I.A50-A64.A54   Gonococcal infection

I.A50-A64.A56.0   Chlamydial infections of the lower parts of the genito-urinary tract

I.A50-A64.A56.1   Chlamydial infections of the pelvic organs and other urogenital organs

I.A50-A64.A59   Trichomoniasis

I.A70-A74.A74.9   Chlamydial infection, unspecified

I.B35-B49.B37.3   Candidiasis of the vulva and vagina (N77.1 *)

I.B35-B49.B37.4   Candidiasis of other urogenital localizations

I.B35-B49.B49   Mycosis, unspecified

XIV.N30-N39.N30   Cystitis

XIV.N30-N39.N34   Urethritis and urethral syndrome

XIV.N70-N77.N74.8 *   Inflammatory diseases of female pelvic organs in other diseases classified elsewhere

XIV.N70-N77.N76   Other inflammatory diseases of the vagina and vulva

XIX.T36-T50.T42   Poisoning with anticonvulsant, sedative, hypnotics, and anti-Parkinsonics

XXI.Z40-Z54.Z51.4   Preparatory procedures for subsequent treatment, not elsewhere classified

XIX.T66-T78.T78.8   Other adverse reactions, not elsewhere classified

XX.Y85-Y89.Y88.0   Consequences of adverse effects of medicinal products, medicines and biological substances used for therapeutic purposes

XII.L20-L30.L20.8   Other atopic dermatitis

XII.L20-L30.L21   Seborrheic dermatitis

XII.L20-L30.L23   Allergic contact dermatitis

XII.L20-L30.L24   Simple irritant contact dermatitis

XII.L20-L30.L28.0   Simple chronic lichen

XII.L20-L30.L29   Itching

XII.L20-L30.L30.0   Coin-like eczema

XII.L40-L45.L40   Psoriasis

XII.L50-L54.L50   Hives

XII.L50-L54.L51   Erythema multiforme

XII.L55-L59.L55   Sunburn

XII.L55-L59.L56.2   Photocontact dermatitis [berloque dermatitis]

XII.L55-L59.L58   Radiation dermatitis radiation

X.J30-J39.J30   Vasomotor and allergic rhinitis

X.J40-J47.J44   Other chronic obstructive pulmonary disease

X.J40-J47.J45   Asthma

V.F30-F39.F30   Manic episode

V.F40-F48.F41.0   Panic disorder [episodic paroxysmal anxiety]

V.F40-F48.F41.1   Generalized anxiety disorder

V.F40-F48.F41.2   Mixed anxiety and depressive disorder

V.F40-F48.F43   Reaction to severe stress and adaptation disorders

V.F40-F48.F43.1   Post-Traumatic Stress Disorder

V.F40-F48.F43.2   Disorder of adaptive reactions

V.F40-F48.F45   Somatoform disorders

V.F40-F48.F48.0   Neurasthenia

V.F50-F59.F51.0   Insomnia inorganic etiology

VI.G40-G47.G47.0   Disturbances of falling asleep and maintaining sleep [insomnia]

IX.I80-I89.I83   Varicose veins

XII.L20-L30.L20   Atopic dermatitis

XII.L20-L30.L20.8   Other atopic dermatitis

XII.L20-L30.L21   Seborrheic dermatitis

XII.L20-L30.L23   Allergic contact dermatitis

XII.L20-L30.L24   Simple irritant contact dermatitis

XII.L20-L30.L28.0   Simple chronic lichen

XII.L40-L45.L40   Psoriasis

XII.L40-L45.L43   Lichen red flat

XII.L55-L59.L55   Sunburn

XII.L80-L99.L93.0   Discoid lupus erythematosus

XII.L20-L30.L29.3   Anogenital itching, unspecified

XII.L20-L30.L30.1   Dyshidrosis [pomfolix]

XII.L20-L30.L30.3   Infectious dermatitis

XII.L20-L30.L30.9   Dermatitis, unspecified

XII.L50-L54.L53   Other erythematous conditions

XII.L55-L59.L56.2   Photocontact dermatitis [berloque dermatitis]

XII.L80-L99.L87   Transepidermal perforated changes

XIII.M30-M36.M32   Systemic lupus erythematosus

XIX.T08-T14.T14.0   Superficial injury of unspecified area of ​​the body

XIX.T20-T32.T30   Thermal and chemical burns, unspecified

XIX.T66-T78.T78.4   Allergy, unspecified